ArticleGastroenterology2023

A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23.

Yoshinobu Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.